Pharming Group N.V. Overview

Pharming Group N.V. Total Revenue

Revenue analysis for PHAR.

Quarterly Revenue

$72.71M

↓ 8.07% YoY

As of Mar 2026

Annual Revenue (TTM)

$354.95M

↑ 10.62% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin